Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate progression free survival (PFS) with XL184 treatment as compared with placebo in subjects with unresectable, locally advanced or metastatic medullary thyroid carcinoma (MTC).
Inclusion criteria
- Medullary thyroid carcinoma (MTC)